149 related articles for article (PubMed ID: 858083)
1. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
Hechtman P
Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
[TBL] [Abstract][Full Text] [Related]
2. Purification and properties of the hexosaminidase A-activating protein from human liver.
Hechtman P; LeBlanc D
Biochem J; 1977 Dec; 167(3):693-701. PubMed ID: 603630
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates.
Bach G; Suzuki K
J Biol Chem; 1975 Feb; 250(4):1328-32. PubMed ID: 1112809
[TBL] [Abstract][Full Text] [Related]
4. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.
Hechtman P; Kachra Z
Biochem J; 1980 Mar; 185(3):583-91. PubMed ID: 7387624
[TBL] [Abstract][Full Text] [Related]
5. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
Hechtman P; Gordon BA; Ng Ying Kin NM
Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
[TBL] [Abstract][Full Text] [Related]
8. Substrate binding properties of the human liver hexosaminidase A activator protein.
Hechtman P; Isaacs C; Smith-Jones L
Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
[TBL] [Abstract][Full Text] [Related]
9. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
Kytzia HJ; Sandhoff K
J Biol Chem; 1985 Jun; 260(12):7568-72. PubMed ID: 3158659
[TBL] [Abstract][Full Text] [Related]
10. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
Burg J; Banerjee A; Conzelmann E; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):821-9. PubMed ID: 6225718
[TBL] [Abstract][Full Text] [Related]
11. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
Hirabayashi Y; Li YT; Li SC
J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
Conzelmann E; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
[TBL] [Abstract][Full Text] [Related]
13. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
14. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
Conzelmann E; Burg J; Stephan G; Sandhoff K
Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
[TBL] [Abstract][Full Text] [Related]
15. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
[No Abstract] [Full Text] [Related]
17. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Inui K; Grebner EE; Jackson LG; Wenger DA
Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2.
Hasilik A; von Figura K; Conzelmann E; Nehrkorn H; Sandhoff K
Eur J Biochem; 1982 Jul; 125(2):317-21. PubMed ID: 6214395
[TBL] [Abstract][Full Text] [Related]
19. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
Erzberger A; Conzelmann E; Sandhoff K
Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
